Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases

Randomized Phase Ii ◽

Breast Cancer Brain Metastases ◽

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-4852-5 ◽

2018 ◽

Vol 171 (3) ◽

pp. 637-648 ◽

Cited By ~ 14

Author(s):

Amanda E. D. Van Swearingen ◽

Marni B. Siegel ◽

Allison M. Deal ◽

Maria J. Sambade ◽

Alan Hoyle ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Breast Cancer Brain Metastases ◽

Faculty Opinions recommendation of Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.724195112.793501041 ◽

2014 ◽

Author(s):

Minesh Mehta ◽

Manmeet Ahluwalia

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Multicenter Phase ◽

All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer – A phase II study

Journal of the Egyptian National Cancer Institute ◽

10.1016/j.jnci.2014.08.001 ◽

2014 ◽

Vol 26 (4) ◽

pp. 187-194 ◽

Cited By ~ 9

Author(s):

Hanan Shawky ◽

Hesham Tawfik

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-08-1080 ◽

2009 ◽

Vol 15 (4) ◽

pp. 1452-1459 ◽

Cited By ~ 429

Author(s):

Nancy U. Lin ◽

Véronique Diéras ◽

Devchand Paul ◽

Dominique Lossignol ◽

Christos Christodoulou ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Multicenter Phase ◽

S5-1: Neoadjuvant Pertuzumab (P) and Trastuzumab (H): Biomarker Analyses of a 4-Arm Randomized Phase II Study (NeoSphere) in Patients (pts) with HER2−Positive Breast Cancer (BC).

10.1158/0008-5472.sabcs11-s5-1 ◽

2011 ◽

Cited By ~ 10

Author(s):

L Gianni ◽

G Bianchini ◽

A Kiermaier ◽

G Bianchi ◽

Y-H Im ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Randomized Phase Ii ◽

Abstract P2-16-02: Bevacizumab, etoposide, and cisplatin (BEEP) is highly effective in brain metastases of HER2 positive breast cancer progressing from whole brain radiotherapy - Subgroup analysis of a multi-center phase II study

10.1158/0008-5472.sabcs13-p2-16-02 ◽

2013 ◽

Author(s):

Y-S Lu ◽

W-W Chen ◽

C-H Lin ◽

D-C Yeh ◽

L-M Tseng ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Subgroup Analysis ◽

Phase Ii Study ◽

Whole Brain Radiotherapy ◽

Her2 Positive ◽

Brain Radiotherapy ◽

Abstract P5-19-07: Randomized Phase II trial of afatinib alone or with vinorelbine versus investigator's choice of treatment in patients with HER2-positive breast cancer with progressive brain metastases after trastuzumab and/or lapatinib-based therapy: LUX-Breast 3

10.1158/1538-7445.sabcs14-p5-19-07 ◽

2015 ◽

Cited By ~ 2

Author(s):

Javier Cortés ◽

Veronique Dieras ◽

Jungsil Ro ◽

Jérôme Barriere ◽

Thomas Bachelot ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Trial ◽

Her2 Positive ◽

Randomized Phase Ii ◽

Choice Of Treatment ◽

Abstract OT1-08-05: Phase II trial of GDC-0084 in combination with trastuzumab for patients with HER2-positive breast cancer brain metastases (BCBM)

10.1158/1538-7445.sabcs19-ot1-08-05 ◽

2020 ◽

Author(s):

Jose P Leone ◽

Lorenzo Trippa ◽

Lindsey Milisits ◽

Chelsea Andrews ◽

Jennifer Ligibel ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Trial ◽

Her2 Positive ◽

Breast Cancer Brain Metastases ◽

Abstract GS1-05: TBCRC 033: A randomized phase II study of adjuvant trastuzumab emtansine (T-DM1) vs paclitaxel (T) in combination with trastuzumab (H) for stage I HER2-positive breast cancer (BC) (ATEMPT)

10.1158/1538-7445.sabcs19-gs1-05 ◽

2020 ◽

Cited By ~ 1

Author(s):

Sara M Tolaney ◽

Lorenzo Trippa ◽

William Barry ◽

Jiani Hu ◽

Chau Dang ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Stage I ◽

Trastuzumab Emtansine ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Randomized Phase Ii ◽

Randomized Phase II Study of Primary Systemic Chemotherapy and Trastuzumab for Operable HER2 Positive Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2011.10.002 ◽

2012 ◽

Vol 12 (1) ◽

pp. 49-56 ◽

Cited By ~ 7

Author(s):

Seigo Nakamura ◽

Masashi Ando ◽

Norikazu Masuda ◽

Kenjiro Aogi ◽

Hiroyo Ino ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Systemic Chemotherapy ◽

Phase Ii Study ◽

Her2 Positive ◽

Primary Systemic Chemotherapy ◽

Randomized Phase Ii ◽